NUC-202

N/A

Report date: 2025/01/26 16:31:53
NME

Base Information

Drug NameNUC-202
Drug Alias NameNUC-202
ClassificationSmall molecules > Prodrug > Directed prodrug therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, HepatocellularNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNucorion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A